Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT02775539 Not yet recruiting - Heart Failure Clinical Trials

Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure

SPHERE-HF
Start date: June 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of mirabegron (a B3 adrenergic receptor agonist) in patients with pulmonary hypertension secondary to heart failure by conducting a randomized multicenter phase II placebo-controlled clinical trial.

NCT ID: NCT02773511 Not yet recruiting - Clinical trials for Treatment for Type I Humeral Condyle Fracture

Multi-center Study on Surgical or Non-surgical Treatment for Children Type 1 Humeral Condyle Fracture

Start date: July 2016
Phase: N/A
Study type: Interventional

The study evaluates the effectiveness of surgical or non-surgical treatment for children type 1 humeral condyle fracture.Half of the participants receive surgical treatment and the other half receive non-surgical treatment

NCT ID: NCT02773017 Not yet recruiting - Clinical trials for Combined Spinal-epidural Anesthesia

The ED50 of DEX for Providing Sedation in Different Female Age Group

Start date: June 2016
Phase: Phase 4
Study type: Interventional

Dexmedetomidine(DEX) could provide dose-dependent sedation , analgesia , anti-anxiety and inhibition of sympathetic nerves and other effects. Because of its minimal impact on the respiratory , currently it was more and more widely used to sedate patients undergoing regional anesthesia.Many anesthetic pharmacokinetics and pharmacodynamics are often affected by age, and current studies with regard to the effects of age on dexmedetomidine pharmacodynamic are rare. This study was designed to explore the right DEX dose of different female Age of patients to produce suitable sedation.Dexmedetomidine be used in patients with combined spinal and epidural anesthesia for sedation,which is monitored by the Narcotrend,during the operation.The relation between Narcotrend index (NTI) and the depth of sedation for patients is also investigated.

NCT ID: NCT02763449 Not yet recruiting - Clinical trials for Physical Activity and Sedentary Behavior

Appetite and Adiposity Across a Continuum of Activity

AAA
Start date: May 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to understand what happens when someone either becomes more active or more inactive. This study will measure your energy intake, energy expenditure, and body composition under normal conditions, when you become active, and when you become inactive.

NCT ID: NCT02762058 Not yet recruiting - Clinical trials for Acquired Brain Injury Including Stroke

Virtual Reality Mirror Therapy for Those With Acquired Brain Injury: A Clinical Pilot Study

Start date: June 2016
Phase: N/A
Study type: Interventional

The goal of this study is to investigate the effects of virtual reality based mirror therapy (VMT) on individuals with acquired brain injury when compared to a control group receiving traditional mirror therapy (TMT). This is a randomized controlled pilot study in which patients with hemiplegia will be assigned to VMT or TMT and the impact on upper extremity function will be observed.

NCT ID: NCT02759510 Not yet recruiting - Clinical trials for Hemodynamic Instability

Cardiac Output Changes in Cesarean Section

Start date: June 2016
Phase: Phase 0
Study type: Interventional

Since 2011, phenylephrine was recommended as the preferred drug to maintain blood pressure in obstetric anesthesia.Phenylephrine, an α adrenoceptor agonist, can induce peripheral vasoconstriction to maintain blood pressure, while reflexly decrease heart rate and result in cardiac output (CO) reduction.Norepinephrine acts not only as an α adrenoceptor receptor agonist, but also as a weaker β adrenergic receptor agonist. It can elevate blood pressure the same asphenylephrine, meanwhile produce positive inotropic effect including increasing heart rate.Thus, the administration of norepinephrine can maintain blood pressue and avoid the decline of CO. The purpose of this study is to evaluate the effect of norepinephrine and phenylephrine on maternal CO in cesarean section by transesophageal echocardiography.

NCT ID: NCT02758977 Not yet recruiting - Surgery Clinical Trials

Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM)

ALPPSforCRLM
Start date: May 2016
Phase: N/A
Study type: Interventional

Surgical resection has offered the best option for prolonged survival in patients with colorectal liver metastases. Limiting factor for major liver resections is the size of the future liver remnant (FLR). In case of normal liver function, 30% of the total liver volume is considered to be sufficient to maintain adequate liver function after resection. In an attempt to further increase "resectability" criteria for patients with too small FLR surgical and interventional maneuvers such as portal vein embolization and portal vein ligation in two-stage hepatectomies have been implemented, but they need an interval of 4-8 weeks to achieve sufficient hypertrophy. In order to obtain adequate but rapid parenchymal hypertrophy a new surgical two-step technique, ALPPS, was introduced for oncological patients requiring extended hepatic resection with limited functional reserve. Both procedures can be performed with acceptable morbidity and mortality. The investigators conclude that it is time to perform a randomized study comparing the two surgical approaches in regard to oncological outcome.

NCT ID: NCT02757586 Not yet recruiting - Clinical trials for Leukemia, Lymphocytic, Chronic, B-Cell

Treatment of Chronic Lymphocytic Leukemia

Start date: December 2016
Phase: N/A
Study type: Observational

CLL is a disease of the elderly, identifying effective therapies with better toxicity profiles is thus a high priority, and targeted therapies may allow attainment of this goal.

NCT ID: NCT02757040 Not yet recruiting - Clinical trials for Leukemia, Lymphocytic, Chronic, B-Cell

Combination of Ibrutinib and As2O3 in the Treatment of CLL

Start date: December 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether the combination of As2O3 and ibrutinib is synergistic in chronic lymphocytic leukemia

NCT ID: NCT02756416 Not yet recruiting - Clinical trials for Reversible Cerebral Vasoconstriction Syndrome

Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome

Start date: July 2016
Phase: N/A
Study type: Interventional

This study aims to quantify perfusion, assess arterial vasoconstriction, and confirm reversibility using 3T ASL-MRI and MRA in 10 patients with suspected RCVS. Acquiring these data at multiple time points during RCVS progression, the investigators will assess the relationship between vasoconstriction and downstream perfusion and determine the role of these imaging techniques in early and accurate diagnosis of RCVS. The investigators also aim to investigate whether early imaging abnormalities can predict RCVS complications and clinical outcomes.